Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Quadrivalent Influenza Virus Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT04997239
What this trial is testing

A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 600
Testing effectiveness (Phase 2)Study completedNCT04850898
What this trial is testing

Study of SAB-176 in Healthy Adult Participants

Who this might be right for
Influenza A H1N1
SAb Biotherapeutics, Inc. 62
Early research (Phase 1)UnknownNCT02015494
What this trial is testing

Phase 1 Safety Study of Recombinant Influenza Vaccine for Prevention

Who this might be right for
Influenza
VaxInnate Corporation 316
Post-approval studies (Phase 4)Study completedNCT02908269
What this trial is testing

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 180
Post-approval studies (Phase 4)Study completedNCT07710586
What this trial is testing

Preliminary Safety Assessment of a Quadrivalent Subunit Influenza Vaccine in China

Who this might be right for
Influenza Vaccine
Ab&B Bio-tech Co., Ltd.JS 3,105
Large-scale testing (Phase 3)Study completedNCT03321968
What this trial is testing

Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults

Who this might be right for
Virus DiseasesRNA Virus InfectionsRespiratory Tract Infections+2 more
Medicago 1,202
Not applicableStudy completedNCT06095947
What this trial is testing

Exploration on the Quadrivalent Influenza Vaccine Immunization Schedule for Children Aged 3-8 Years

Who this might be right for
GCP
Hualan Biological Bacterin Co. Ltd. 652
Post-approval studies (Phase 4)Study completedNCT02915302
What this trial is testing

Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 1,950
Large-scale testing (Phase 3)Study completedNCT01992094
What this trial is testing

Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older

Who this might be right for
Influenza
Novartis Vaccines 2,680
Post-approval studies (Phase 4)Study completedNCT01859143
What this trial is testing

Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults

Who this might be right for
InfluenzaHealthy
MedImmune LLC 300
Testing effectiveness (Phase 2)Study completedNCT02474901
What this trial is testing

Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young Adults

Who this might be right for
Human Immunodeficiency Virus (HIV)
University of Colorado, Denver 101
Large-scale testing (Phase 3)Study completedNCT06015282
What this trial is testing

The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older

Who this might be right for
Influenza, Human
Seqirus 7,741
Testing effectiveness (Phase 2)Study completedNCT02553343
What this trial is testing

The Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 792
Large-scale testing (Phase 3)Study completedNCT03853993
What this trial is testing

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

Who this might be right for
Seasonal Influenza
Sinovac Biotech Co., Ltd 2,380
Large-scale testing (Phase 3)Study completedNCT04074928
What this trial is testing

Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects

Who this might be right for
InfluenzaHumanVirus Diseases
Seqirus 2,414
Large-scale testing (Phase 3)Study completedNCT04001504
What this trial is testing

Vaccination Against Influenza to Prevent Cardiovascular Events After Acute Coronary Syndromes

Who this might be right for
Acute Coronary Syndrome
Hospital Israelita Albert Einstein 1,801
Large-scale testing (Phase 3)Study completedNCT06087640
What this trial is testing

A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age

Who this might be right for
Influenza, Human
Seqirus 38,769
Testing effectiveness (Phase 2)Study completedNCT00988143
What this trial is testing

Influenza Virus Vaccines in Children and Adults

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 600
Large-scale testing (Phase 3)Study completedNCT02218697
What this trial is testing

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older

Who this might be right for
Influenza
GlaxoSmithKline 357
Post-approval studies (Phase 4)Study completedNCT01430689
What this trial is testing

Maternal Flu Vaccine Trial in Bamako, Mali

Who this might be right for
Influenza
University of Maryland, Baltimore 4,193
Next Page